U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599761) titled 'A Phase 1 Study to Assess the Effect of Itraconazole on ABBV-722 in Healthy Adult Participants' on May 07.

Brief Summary: The objective of this study is to assess the effect of repeated doses of itraconazole on the single dose pharmacokinetics (PK) of ABBV-722.

Study Start Date: May 05

Study Type: INTERVENTIONAL

Condition: Healthy Volunteers

Intervention: DRUG: ABBV-722

Oral Tablet

DRUG: Itraconazole

Oral Capsule

Recruitment Status: RECRUITING

Sponsor: AbbVie

Disclaimer: Curated by HT Syndication....